Review Article

Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling

Zheng-Jie Chia1,2, Hirushi Kumarapperuma1,2, Ruizhi Zhang1,3, Peter J. Little2,4, Danielle Kamato1,2,3
1 Institute for Biomedicine and Glycomics, Griffith University, Nathan, QLD, Australia
2 School of Pharmacy, The University of Queensland, Woolloongabba, QLD, Australia
3 School of Environment and Science, Griffith Sciences, Griffith University, Nathan, QLD, Australia
4 Department of Pharmacy, Guangzhou Xinhua University, Guangzhou 510520, China
Correspondence to: Danielle Kamato: d.kamato@griffith.edu.au,
DOI: 10.1038/s41401-024-01413-6
Received: 9 July 2024
Accepted: 16 October 2024
Advance online: 6 November 2024

Abstract

The Smad transcription factors are well known for their role at the core of transforming growth factor-β (TGF-β) signalling. However, recent evidence shows that the Smad transcription factors play a vital role downstream of other classes of receptors including G protein-coupled receptors (GPCR). The versatility of Smad transcription factors originated from the two regions that can be differently activated by the TGF-β receptor superfamily or through the recruitment of intracellular kinases stimulated by other receptors classes such as GPCRs. The classic GPCR signalling cascade is further expanded to conditional adoption of the Smad transcription factor under the stimulation of Akt, demonstrating the unique involvement of the Smad transcription factor in GPCR signalling pathways in disease environments. In this review, we provide a summary of the signalling pathways of the Smad transcription factors as an important downstream mediator of GPCRs, presenting exciting opportunities for discovering new therapeutic targets for diseases.
Keywords: transforming growth factor-beta receptor; Smad; transactivation dependent; GPCR signalling; Akt; phospho-Smad

Download Citation

Cited times in Scopus